Michael F Waters Selected Research

Spinocerebellar ataxia 13

10/2018	C-terminal proline deletions in KCNC3 cause delayed channel inactivation and an adult-onset progressive SCA13 with spasticity.
11/2014	KCNC3(R420H), a K(+) channel mutation causative in spinocerebellar ataxia 13 displays aberrant intracellular trafficking.
1/2013	Mutation in the kv3.3 voltage-gated potassium channel causing spinocerebellar ataxia 13 disrupts sound-localization mechanisms.
3/2011	Frequency of KCNC3 DNA variants as causes of spinocerebellar ataxia 13 (SCA13).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael F Waters Research Topics

Disease

23	Stroke (Strokes) 01/2021 - 10/2010
11	Ischemic Stroke 11/2018 - 01/2011
6	Pathologic Constriction (Stenosis) 12/2018 - 09/2010
4	Spinocerebellar ataxia 13 10/2018 - 03/2011
3	Infarction (Infarctions) 01/2020 - 03/2016
2	Cognitive Dysfunction 10/2022 - 01/2017
2	Intracranial Vasospasm 01/2015 - 11/2014
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2015 - 11/2014
2	Inflammation (Inflammations) 03/2014 - 01/2014
2	Seizures (Absence Seizure) 01/2014 - 02/2012
2	Thrombosis (Thrombus) 03/2012 - 09/2010
1	Atrophy 10/2022
1	Brain Ischemia (Cerebral Ischemia) 10/2022
1	Alzheimer Disease (Alzheimer's Disease) 10/2022
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Brain Infarction 01/2020
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 11/2018
1	Cerebral Infarction 01/2018
1	Central Nervous System Diseases (CNS Diseases) 01/2018
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2017
1	Deglutition Disorders (Dysphagia) 01/2017
1	Dysarthria (Spastic Dysarthria) 01/2017
1	Epilepsy (Aura) 01/2017
1	Diabetes Mellitus 03/2016
1	Traumatic Brain Injuries (Traumatic Brain Injury) 11/2014
1	Ischemia 11/2014
1	Treatment-Resistant Depressive Disorder 01/2014
1	Edema (Dropsy) 01/2014
1	Vertebrobasilar Insufficiency 09/2013
1	Hemorrhagic Stroke 10/2012
1	Paralysis (Palsy) 05/2012
1	Intracranial Sinus Thrombosis (Sinus Thrombosis) 03/2012
1	Hypoglycemia (Reactive Hypoglycemia) 02/2012
1	Migraine Disorders (Migraine) 02/2012
1	Neoplasms (Cancer) 02/2012
1	Transient Ischemic Attack 09/2011
1	Hematoma 08/2011
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 03/2011
1	Myocardial Infarction 09/2010
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2006

Drug/Important Bio-Agent (IBA)

4	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2018 - 09/2010
4	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 11/2014 - 04/2006
2	Endothelin-1 (Endothelin 1)IBA 01/2018 - 11/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 03/2016
2	Cytidine Triphosphate (CTP)IBA 02/2012 - 01/2012
1	complement C3a receptorIBA 10/2022
1	Deoxyribonuclease I (Nickase)IBA 01/2020
1	SB 290157IBA 01/2020
1	Fingolimod Hydrochloride (FTY720)FDA Link 11/2018
1	Potassium Channels (Potassium Channel)IBA 10/2018
1	Neuroprotective AgentsIBA 01/2018
1	compound 21IBA 01/2018
1	Angiotensin IIIBA 01/2018
1	Retinaldehyde (Retinal)IBA 01/2017
1	Angiotensin-Converting Enzyme 2IBA 07/2016
1	CarboxypeptidasesIBA 07/2016
1	Cytochrome P-450 CYP2C19IBA 06/2016
1	Warfarin (Coumadin)FDA LinkGeneric 03/2016
1	HaptoglobinsIBA 01/2015
1	Indicators and Reagents (Reagents)IBA 03/2014
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 03/2014
1	Serotonin (5 Hydroxytryptamine)IBA 01/2014
1	Glutamic Acid (Glutamate)FDA Link 01/2014
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2014
1	GadoliniumIBA 09/2013
1	danaparoid (Orgaran)FDA Link 04/2013
1	Clopidogrel (Plavix)FDA Link 10/2012
1	Heparin (Liquaemin)FDA LinkGeneric 03/2012
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2012
1	DNA (Deoxyribonucleic Acid)IBA 03/2011
1	Abciximab (ReoPro)FDA Link 09/2010

Therapy/Procedure

15	Therapeutics 01/2020 - 01/2011
5	Stents 01/2014 - 09/2010
2	Neurological Rehabilitation 01/2021 - 08/2020
2	Thrombectomy 04/2013 - 03/2012
1	Lasers (Laser) 10/2022
1	Carotid Endarterectomy 04/2020
1	Complementary Therapies (Alternative Medicine) 03/2016
1	Ligation 03/2016
1	Vagus Nerve Stimulation 01/2014
1	Contraindications 10/2012
1	Anesthesia 05/2012
1	Catheters 03/2012
1	Intravenous Administration 08/2011
1	Craniotomy 08/2011
1	Embolectomy 01/2011
1	Cerebral Revascularization 01/2011
1	Length of Stay 10/2010